ROIV

ABUS Biotechnology MRNA Petri Dish Reports ROIV Uncategorized

Why Moderna’s $950M Patent Bill Is A Small Price For Pipeline Freedom

Mar 4, 2026

ABUS Biotechnology MRNA ROIV Uncategorized

Moderna gains as Arbutus/ Genevant settlement removes major financial risk

Mar 4, 2026

ABUS Biotechnology MRNA ROIV Uncategorized

Moderna surges after hours on patent settlement with Arbutus and Genevant

Mar 3, 2026

Biotechnology PFE ROIV Uncategorized

Pfizer – Roivant tie-up generates positive mid-stage data for lead asset

Feb 6, 2026

ABUS Biotechnology MRNA ROIV Uncategorized

Arbutus jumps on ruling in patent dispute with Moderna

Feb 2, 2026